-+ 0.00%
-+ 0.00%
-+ 0.00%

MAIA BIOTECHNOLOGY - PHASE 3 THIO-104 TRIAL ADVANCING TOWARD 2027 INTERIM SURVIVAL ANALYSIS

Reuters·11/17/2026 13:45:00

Please log in to view news